Helicobacter pylori and gastroesophageal reflux disease: to treat or not to treat?
O'Connor
H J
HJ
Dept. of Medicine, General Hospital, Tullamore, Co Offaly, Ireland. Oconnor_hj@hotmail.com
O'Morain
C A
CA
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000009:adverse effects / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D005756:Gastritis / Q000382:microbiology; D005762:Gastroenterology / Q000379:methods / Q000706:statistics & numerical data; D005764:Gastroesophageal Reflux / Q000382:microbiology*; D016481:Helicobacter Infections / Q000150:complications* / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D018579:Patient Selection; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data; D012307:Risk Factors; D013274:Stomach Neoplasms / Q000382:microbiology; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents